INTUITIVE SURGICAL INC
$437.75
−5.84 (−1.32%) · delayed · Nov 16, 2026
Five-year price
52w $328.57 to $603.88
- Market cap
- $151.7B
- Enterprise value
- $148.4B
- P/E
- 55.6×
- 68.0× on 3y avg EPS
- EV / EBIT
- 50.4×
- FCF yield
- 1.6%
- ROIC
- 17.7%
- Debt / equity
- —
- Piotroski F
- 8/9
Value scorecard · FY2025
Does it pass the value tests?
Quality
- ●ROIC > 12% (5y avg)5y avg ROIC 15.4%
- ○ROE > 15% (5y avg)5y avg ROE 14.0%
- ●Stable operating marginsMargin volatility 2.6% (σ, 5y)
- ○Earnings convert to cashFCF / net income 72% (5y avg)
- ●Growing revenueRevenue CAGR 5y 18.2%
- ○Shrinking share countDiluted shares 0.5% over 5y
Value
- ○P/E below 15P/E 55.6
- ○EV/EBIT below 12EV/EBIT 50.4
- ○FCF yield above 6%FCF yield 1.6%
- ○Price below Graham NumberGraham Number $95.42
- ○P/B below 3P/B 8.5
Safety
- –Debt / equity below 0.5D/E n/a
- ●Debt payable in < 4 yrs of earningsNet debt $-3.4B
- –Interest coverage > 8xCoverage n/ax
- ●Current ratio > 1.5Current ratio 4.87
- ●Piotroski F-score ≥ 6F-score 8/9
Graham Defensive
- ●Adequate size (revenue > $2B)Revenue $10.1B
- ●Strong condition (current ratio ≥ 2)Current ratio 4.87
- ●Earnings stability (no loss, 10y)10 years of data
- ○Uninterrupted dividendsDividends paid every year on record
- ○Earnings growth ≥ 33% (10y, 3y avgs)EPS growth -10%
- ○Moderate P/E (≤ 15 on 3y avg EPS)P/E (3y avg) 68.0
- ○P/E × P/B ≤ 22.5Product 578.7
Valuation lab
What do you have to believe?
At $437.75, the market is pricing in about 20.2% annual free-cash-flow growth for the next decade (9% discount rate, 2.5% terminal growth).
Starting cash flow
Net debt −$3.4B · 347M shares · 5y revenue CAGR 18.2%
Intrinsic value
$374.28
Price
$437.75
Premium paid
17%
What the price implies
The market is paying for 20.2% annual cash-flow growth for 10 years at a 9.0% discount rate.
Terminal value share
69% of the value sits beyond year 10.
Financial statements
A decade of the record.
USD millions · fiscal years · source: SEC 10-K XBRL
| Line item | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,707 | 3,138 | 3,724 | 4,479 | 4,358 | 5,710 | 6,222 | 7,124 | 8,352 | 10,065 |
| Gross profit | 1,893 | 2,202 | 2,604 | 3,110 | 2,861 | 3,959 | 4,196 | 4,730 | 5,634 | 6,642 |
| Operating income | 950 | 1,063 | 1,199 | 1,375 | 1,050 | 1,821 | 1,577 | 1,767 | 2,349 | 2,946 |
| Operating margin | 35.1% | 33.9% | 32.2% | 30.7% | 24.1% | 31.9% | 25.3% | 24.8% | 28.1% | 29.3% |
| Pre-tax income | 985 | 1,105 | 1,280 | 1,502 | 1,207 | 1,890 | 1,607 | 1,959 | 2,674 | 3,311 |
| Income tax | 247 | 434 | 155 | 120 | 140 | 162 | 262 | 142 | 336 | 435 |
| Net income | 738 | 671 | 1,128 | 1,379 | 1,061 | 1,705 | 1,322 | 1,798 | 2,323 | 2,856 |
| EPS (diluted) | 6.26 | 5.77 | 9.49 | 3.85 | 2.94 | 4.66 | 3.65 | 5.03 | 6.42 | 7.87 |
| Diluted shares | 118 | 116 | 119 | 358 | 361 | 366 | 362 | 357 | 362 | 363 |
Who owns it